In the present study, a novel mechanism of action of NEAT1 was demonstrated to promote tumour development of BC by modulating the miR-101/VEGF-C pathway, providing novel insight into therapeutic application of lncRNAs in BC. This evidence concerns the gene NEAT1 and neoplasm.